IQVIA (NYSE:IQV) Releases FY 2025 Earnings Guidance

IQVIA (NYSE:IQV) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 11.700-12.100 for the period, compared to the consensus earnings per share estimate of 11.830. The company issued revenue guidance of $16.0 billion-$16.4 billion, compared to the consensus revenue estimate of $15.9 billion.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. BTIG Research downgraded IQVIA from a “buy” rating to a “neutral” rating in a research report on Monday, February 3rd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $270.00 target price on shares of IQVIA in a research note on Monday, February 10th. Barclays reissued an “equal weight” rating and issued a $170.00 price target (down from $235.00) on shares of IQVIA in a research note on Thursday, April 10th. HSBC downgraded shares of IQVIA from a “buy” rating to a “hold” rating and dropped their target price for the company from $260.00 to $160.00 in a report on Friday, April 25th. Finally, Hsbc Global Res lowered IQVIA from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 25th. Eight equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, IQVIA presently has an average rating of “Moderate Buy” and an average price target of $237.62.

IQVIA Stock Down 0.8 %

IQV opened at $152.31 on Tuesday. The business has a 50 day moving average price of $166.75 and a two-hundred day moving average price of $190.17. IQVIA has a 52 week low of $135.97 and a 52 week high of $252.88. The company has a market cap of $26.85 billion, a PE ratio of 20.31, a P/E/G ratio of 1.99 and a beta of 1.34. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.12.

IQVIA (NYSE:IQV) last issued its quarterly earnings results on Tuesday, May 6th. The medical research company reported $2.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.62 by ($0.25). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. As a group, research analysts anticipate that IQVIA will post 10.84 EPS for the current year.

Institutional Investors Weigh In On IQVIA

A hedge fund recently raised its stake in IQVIA stock. Brighton Jones LLC grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 244.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,575 shares of the medical research company’s stock after acquiring an additional 2,537 shares during the period. Brighton Jones LLC’s holdings in IQVIA were worth $703,000 at the end of the most recent reporting period. 89.62% of the stock is owned by institutional investors and hedge funds.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.